Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-15
2005-03-15
Huang, Evelyn Mei (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S157000, C546S153000
Reexamination Certificate
active
06867219
ABSTRACT:
The invention provides compounds of formula I:wherein Y is F, Cl, Br, methyl or methoxy; and pharmaceutically acceptable salts thereof. The compounds are effective antitumor agents. The invention also provides pharmaceutical compositions comprising a compound of formula I or a salt thereof, intermediates useful for preparing a compound of formula I, and therapeutic methods comprising administering a compound of formula I or a salt thereof to a mammal in need thereof.
REFERENCES:
patent: 4629493 (1986-12-01), Ura et al.
patent: 5250690 (1993-10-01), Turner et al.
patent: 5364831 (1994-11-01), Yasukazu et al.
patent: 6197728 (2001-03-01), Yasukazu et al.
Draetta et al. “Section V. Topics in Biology”, Annual Reports in Medicinal Chemistry, 31, 1996, Academic Press, San Diego, pp 241-246.*
Salmon et al., “Principles of Cancer Therapy”, Oncology, XIV, pp 1036-1049, 1999.*
Balasubramanian et al. “recent Developments in Cancer, etc.,” Annual Reports in Medicinal Chemistry, 33, 1998, Academic Press, San Diego, pp 151-159.*
Hazeldine, Stuart T., et al., “J. Med. Chem. 2001, 44”,Design, Synthesis, and Biological Evaluation of Analogues of Design, Synthesis, and Biological Evaluation of Analogues of the Antitumor Agent, 2-(4-[(7-Chloro-2-quinoxalinyl)oxy]phenoxy)proplonic Acid(XK469), (2001), p. 1758-1776.
Hazeldine, Stuart T., et al., “J. Med. Chem. 2002, 45”,II, Synthesis and Biological Evaluation of Some Bioisosteres and Congeners of the Antitumor Agent, 2-(4-[97-Chloro-2-quinoxalinyl)oxy]phenoxylproplonic Acid(XK469), (2002), p. 3130-3137.
Corbett, Thomas , et al., “Preclinical Antitumor Efficacy of Analogs of XK469:sodium-(s-{4-(7-chloro-2-quinoxalinyloxy) phenoxy}propionate”,Investigational New Drugs, (1998), 129-139.
Corbett Thomas H.
Hazeldine Stuart T.
Horwitz Jerome P.
Polin Lisa
Huang Evelyn Mei
Schwegman Lundberg Woessner & Kluth P.A.
Wayne State University
LandOfFree
Antitumor agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antitumor agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3391327